Back to Search Start Over

Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome

Authors :
Obis study investigators
M Acalovschi
Y P Uspensky
C Kalayci
Pere Clavé
Jan Tack
J K Triantafillidis
Shee
Source :
Alimentary Pharmacology & Therapeutics. 34:432-442
Publication Year :
2011
Publisher :
Wiley, 2011.

Abstract

Otilonium bromide (OB) is a spasmolytic agent that blocks L-Type Calcium channels in human colonic smooth muscle.

Details

ISSN :
02692813
Volume :
34
Database :
OpenAIRE
Journal :
Alimentary Pharmacology & Therapeutics
Accession number :
edsair.doi...........cafe981f8684773939a3bb222abe05af
Full Text :
https://doi.org/10.1111/j.1365-2036.2011.04730.x